CSIMarket Company Name, Ticker, Customers, else..
 
Biosig Technologies Inc   (BSGM)
Other Ticker:  
 
 
Price: $0.4478 $0.00 -0.022%
Day's High: $0.4479 Week Perf: -0.11 %
Day's Low: $ 0.34 30 Day Perf: 11.17 %
Volume (M): 8 52 Wk High: $ 2.98
Volume (M$): $ 3 52 Wk Avg: $0.68
Open: $0.34 52 Wk Low: $0.14



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 10
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Biosig Technologies Inc
Biosig Technologies Inc is a medical technology company that designs, develops, and commercializes advanced biomedical signal processing systems. Their main product, the PURE EP System, is used for recording, analyzing, and displaying electrophysiological signals for diagnostic and therapeutic procedures in the field of cardiology. This system aims to improve the accuracy, efficiency, and effectiveness of procedures such as ablation, which involves the removal or destruction of abnormal heart tissue. Biosig Technologies focuses on providing innovative solutions that enhance the capabilities of healthcare professionals and ultimately improve patient outcomes in the cardiac electrophysiology field.


   Company Address: 55 Greens Farms Road Westport 6880 CT
   Company Phone Number: 409-5444   Stock Exchange / Ticker: NASDAQ BSGM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Merger and Acquisition

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

Published Wed, Jul 31 2024 1:45 PM UTC


Los Angeles, July 31, 2024 ? A Significant Step Towards Cutting-Edge Electrophysiology Solutions
In a transformative move poised to enhance its market position within the healthcare technology landscape, BioSig Technologies, Inc. (OTCQB: BSGM) has announced its intent to acquire the assets of Neuro-Kinesis Corporation (NKC), a privately-held company specializing in ...
Announcement

BioSig Technologies Streamlines Operations, Achieves Significant Payables Reduction Under New Leadership

Published Thu, Jul 25 2024 5:57 PM UTC

In a noteworthy development within the medical technology sector, BioSig Technologies, Inc. (OTCQB: BSGM) has announced a significant improvement to its financial standing by negotiating a reduction in outstanding payables amounting to approximately $1.5 million during the second quarter of 2024. This strategic move comes in the wake of new management taking the reins, signa...
Announcement

BioSig Technologies Bolsters Leadership Team with New CFO and CEO Appointments, Completes Board Realignme...

Published Mon, Jun 10 2024 1:45 PM UTC

'By ''Westport, CT ?? June 10, 2024'In a strategic move to bolster its leadership team, BioSig Technologies, Inc. (NASDAQ: BSGM), a pioneering medical technology company specializing in intra-cardiac signal visualization, has announced the appointment of Mr. Ferdinand Groenewald as its interim Chief Financial Officer and Principal Accounting Officer. This announcement follow...
Financing Agreement

BioSig Technologies, Inc. Implements $3 Million Registered Direct Offering, Fueling Advancements in Intracardiac Signal Visualization

Published Thu, May 30 2024 12:01 PM UTC

BioSig Technologies, Inc. (NASDAQ: BSGM) has recently made a significant announcement regarding its financial transactions. The medical technology company, focused on providing precise and accurate intracardiac signal visualization, disclosed that it has entered into definitive agreements for a registered direct offering. This offering will involve the issuance and sale of 1...
Announcement

BioSig Technologies Implements Strategic Restructuring Plan and Welcomes New CEO to Drive Growth and Improve Operational Efficiency

Published Tue, May 21 2024 3:10 PM UTC

Westport, CT, May 21, 2024 - BioSig Technologies, Inc. (Nasdaq: BSGM), a pioneering medical technology company that specializes in intra-cardiac signal visualization, has recently released an important Letter to Shareholders. The company's Chief Executive Officer, Mr. Anthony Amato, conveyed this letter to provide updates on significant developments within BioSig and outline...






Biosig Technologies Inc's Segments
Corporate Segment    100 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com